On the reduced delisting risk of ordinary shares of Gossamer Bio, Inc. (GOSS)

The International Trading System Limited (hereinafter – ITS) hereby informs on the reduced delisting risk of ordinary shares of Gossamer Bio, Inc. (ISIN US38341P1021, hereinafter – Shares, QI) from The NASDAQ Stock Market LLC (hereinafter - Nasdaq).

Information on delisting risk of ordinary shares by Nasdaq

On July 18, 2024 Gossamer Bio, Inc. (hereinafter – the Company) submitted Current report Form 8-K to The United States Securities and Exchange Commission (hereinafter - SEC). According to the report, on July 18, 2024, the Company announced that it had received notice from Nasdaq that it was back in compliance with the minimum price listing requirement. For more information, please refer to the report available on the SEC website.

Information regarding possible actions to be taken by ITS Ltd.

ITS Ltd. conducts regular monitoring of the relevant information disclosed by the Company and notes that such a delinquency previously occurred and later was eliminated. Delisting of the Shares by Nasdaq will be considered to constitute a breach of the ITS Regulations on admitting financial instruments to trading and result in termination of trading in the QI on ITS.